The Clinical Research Management Office (CRMO) is the administrative shared resource for the conduct of clinical search at the LCC. The Director of the CRMO, Michael J. Hawkins, M.D., has extensive experience in the conduct and administration of clinical research. The functions of the CRMO are to: facilitate the conduct of clinical search by providing support to clinical researchers and provide regulatory oversight of clinical research. The supervisor for Research Nursing (SRN) has 17 years of clinical oncology, research, and managerial experience and has direct supervisory responsibility for 11 research nurses, 3 data managers, 3 research assistants and 2 protocol coordinators. The Protocol Office, under the SRN's supervision, maintains files on each protocol submitted to the CRMO, submits protocols, amendments, annual reviews and adverse drug reaction reports to the IRB; and maintains current copies of open protocols throughout the LCC. The Supervisor of Research Operations has over 10 years of broad and extensive nursing experience and is responsible for quality control of the CRMO and implementation of new procedures. Support for two research nurses assigned to pilot institutional trials in bon arrow transplantation and developmental therapeutics is also requested in this application. With considerable support from the LCC, the CRMO has established a Clinical Research Database that contains data on each patient who goes onto a clinical protocol, electronically downloads data from the Georgetown Hospital Information System, d provides weekly reports for investigators on LCC single institution trials. Since the last CCSG review, the CRMO, together with the Clinical Protocol Review and Monitoring system and the Biostatistics Shared Resource, been extensively reorganized under new leadership to provides strong and extensive support for LCC clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-10
Application #
6203163
Study Section
Project Start
1999-07-30
Project End
2000-04-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Pohlmann, Paula R; Isaacs, Claudine (2018) Extended Adjuvant Endocrine Therapy for Postmenopausal Women: Treating Many to Benefit a Few. J Natl Cancer Inst 110:
Fu, Ying; Silverstein, Shana; McCutcheon, Justine N et al. (2018) An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice. Hepatology 67:159-170
Stires, Hillary; Heckler, Mary M; Fu, Xiaoyong et al. (2018) Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Mol Cell Endocrinol 471:105-117
Xiao, David; Zheng, Chaoyi; Jindal, Manila et al. (2018) Medicaid Expansion and Disparity Reduction in Surgical Cancer Care at High-Quality Hospitals. J Am Coll Surg 226:22-29
Kozlik, Petr; Goldman, Radoslav; Sanda, Miloslav (2018) Hydrophilic interaction liquid chromatography in the separation of glycopeptides and their isomers. Anal Bioanal Chem 410:5001-5008
Zheng, Wenjie; Wu, Xiuhua; Goudarzi, Maryam et al. (2018) Metabolomic alterations associated with Behçet's disease. Arthritis Res Ther 20:214
Getnet, Derese; Gautam, Aarti; Kumar, Raina et al. (2018) Poisoning with Soman, an Organophosphorus Nerve Agent, Alters Fecal Bacterial Biota and Urine Metabolites: a case for Novel Signatures for Asymptomatic Nerve Agent Exposure. Appl Environ Microbiol :
Bluethmann, Shirley M; Sciamanna, Christopher N; Winkels, Renate M et al. (2018) Healthy Living After Cancer Treatment: Considerations for Clinical and Community Practice. Am J Lifestyle Med 12:215-219
Graves, Kristi D; Hall, Michael J; Tercyak, Kenneth P (2018) Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for translational behavioral medicine research, practice, and policy. Transl Behav Med 8:4-6
Aldeghaither, Dalal S; Zahavi, David J; Murray, Joseph C et al. (2018) A Mechanism of Resistance to Antibody-Targeted Immune Attack. Cancer Immunol Res :

Showing the most recent 10 out of 1120 publications